In this study, for the first time, we examined the expression patterns and clinical significance of both OCT4 and NANOG as CSC markers in RCC and its subtypes using tissue microarray (TMA) based immunohistochemistry (IHC) technique. This evidence concerns the gene NANOG and renal cell carcinoma.